About this raise: Polaris Quantum Biotech, with a valuation of $11.5 million, is raising funds on OurCrowd through Reg D 506(c) raise. The company uses the latest innovations in cloud and quantum computing, artificial intelligence, and machine learning to develop new drugs in a fraction of the time and cost of conventional methods. The platform and technology of Polaris Quantum Biotech scan billions of molecules from a large chemical space to find the molecules most suitable for drug development. Dr. Shahar Keinan and Bill Shipman founded Polaris Quantum Biotech in 2020. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1,630,000. The campaign proceeds will be used for growth and expansion.
Investment Overview
Deal Terms
- Platform
- OurCrowd
- Start Date
- 04/19/2021
- Close Date
- 07/23/2021
$10,000
$1,630,000
$10,000
Equity - Common
RegD 506(c)
$11,500,000
Company & Team
Company
- Year Founded
- 2020
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Location
- Durham, North Carolina
- Company Website
-
Visit Website
Team
Financials
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Company Funding & Growth
Funding history
Growth Charts
Revenue History
Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.
Valuation History
Price per Share History
Note: Share prices shown in earlier rounds may not be indicative of any stock splits.